Welcome

Investor Contact

Media & Investor Relations:
Troy Wichterman
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com

Investor Alerts

Investor Home

Investor Presentation

BioLife Solutions Investor Presentation October 2024

Recent Events

BioLife Solutions, Inc. Q3 2024 Earnings Conference Call and Business Update

Tuesday, November 12, 2024

1:30pm - 2:30pm PST

Add to Calendar

Set Email Reminder

Latest News

Get News Alerts by Email

Oct 31, 2024

BioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapies ("CGT") and broader biopharma markets, today...

Aug 08, 2024

BioLife Solutions Reports Second Quarter 2024 Financial Results

Cell Processing revenue increased 11% sequentially to $18.0 million GAAP gross margin of 51% and non-GAAP adjusted gross margin of 52% GAAP net loss from continuing operations of $7.1 million and...

View All News and Press Releases